Adults with type 1 diabetes who used a GLP-1 receptor agonist or other incretin-based drug had lower risk for all-cause ...

New studies raise the possibility that GLP-1 medications beat aspirin in reducing colorectal cancer risk, and may improve outcomes for people who do develop the disease.

Ozempic may be more expensive and harder to find now that compounded semaglutide isn’t available. Here are seven reputable ...